The role of PPARy in bile duct ligation-induced hepatic injury in rats
The role of PPARy in bile duct ligation-induced hepatic injury in rats
批准号:
18591511
负责人:
YOKOYAMA Yukihiro
金额:
$2.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
胆管结扎(BDL)后24小时采集的血中血清15d-PJ2水平显著升高。这一结果表明15d-PGJ2的释放在BDL后的早期过程中上调,也提示BDL后pparty系统被激活,BDL后的肝损伤与炎症反应的激活和血管收缩物的产生上调密切相关。我们采用实时RT-PCR检测Sham、BDL和GW9662中炎症因子和血管收缩基因的基因表达,并检测IL-1β、IL-6、IL-12、IFNy和TNF-α作为代表性炎症因子的基因表达。检测ET-1和TXA2合成酶(TXS)作为代表性血管收缩因子的基因表达。BDL后,所有炎症细胞因子基因的表达均上调,这些变化在给药GW9662后进一步增强。与Sham组相比,BDL组血清ROS水平显著升高,GW9662治疗对ROS水平无影响。这些结果表明,pparty的激活通过减少炎症细胞因子和血管收缩剂的产生来保护肝脏免受肝损伤。pparty激活可能是BDL大鼠肝损伤的有效治疗选择。
英文摘要
Serum 15d-PJ2 levels were significantly increased in the blood collected 24h after bile duct ligation(BDL). This result indicated that the release of 15d-PGJ2 was upregulated during the early time course after BDL The result also suggested that PPARy system is activated after BDLThe liver injury after BDL is closely related to the activation of inflammatory response and upregulated production of vasoconstrictors. We examined the gene expression of inflammatory cytokines as well as vasoconstrictor genes in Sham, BDL and GW9662 using real-time RT-PCR The gene expression of IL-1β, IL-6, IL-12, IFNy, and TNF-α were measured as representative inflammatory cytokines. The gene expression of ET-1 and TXA2 synthase(TXS) were examined as representative vasoconstrictors. The expression of all inflammatory cytokine genes were upregulated after BDL These changes were further enhanced by an administration of GW9662. The levels of serum ROS in BDL group was significantly higher as compared to those in Sham group, either the treatment with GW9662 did not affect the levels of ROS.These results indicated that the activation of PPARy protects the liver against hepatic injury through the attenuated production of inflammatory cytokines and vasoconstrictors. PPARy activation might be a potent therapeutic option for hepatic injury in BDL rats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of PPARy in bile duct ligation-induced hepatic injury in rats
PPARγ在胆管结扎所致大鼠肝损伤中的作用
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Tomomi, Kitagawa]
通讯作者:
Kitagawa
The role of PPARγ in bile duct ligation-induced hepatic injury in rats.
PPARγ在胆管结扎所致大鼠肝损伤中的作用。
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Yukihiro, Yokoyama, Tomomi Kitagawa]
通讯作者:
Tomomi Kitagawa
The role of calcitonin in the early phase of liver regeneration and its molecular mechanism.
-
批准号:20591606
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2008
-
负责人:YOKOYAMA Yukihiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
稳定期COPD中医证型的脂代谢紊乱特征及PPARγ/CPT1A调控机制及临床研究
-
批准号:JCZRLH202601649
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“郁痰”理论探讨海藻消瘤胶囊调控ERα-PPARγ轴抑制PTC细胞代谢失衡的作用机制
-
批准号:JCZRLH202601582
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IPA靶向FABP4/PPARγ信号通路改善肥胖相关性肾小球疾病
-
批准号:2026JJ81107
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺超
-
依托单位:
M2巨噬细胞外泌体通过MEG3/PPARγ/Nrf2轴介导铁死亡抑制子痫前期进展的作用及机制研究
-
批准号:2026JJ50641
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:喻玲
-
依托单位:
基于PPARα—肠道菌群—代谢物探讨非诺贝特改善高尿酸血症性肾病的作用及机制研究
-
批准号:2026JJ60065
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李璐
-
依托单位:
GPER激活通过PPARγ抑制小胶质细胞脂滴累积缓解绝经期抑郁
-
批准号:2026JJ82277
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈亮
-
依托单位:
BMP4 p.H251Y突变抑制巨噬细胞PPARγ-LXRα-ABCA1/G1通路导致青年冠心病的机制研究
-
批准号:JCZRLH202601083
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
涤痰益智汤通过PPARα/PGC-1α/PDK4信号轴重塑线粒体能量代谢稳态治疗血管性痴呆的机制研究
-
批准号:JCZRLH202601058
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
蒲公英甾醇通过 PPAR 通路调控巨噬细胞 M2极化减轻肝细胞凋亡抑制高毒力肺炎克雷伯菌致肝脓肿形成的机制研究
-
批准号:ZCLMS26H2002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙瑶
-
依托单位:
基于PPARγ/PGC1α信号通路探究Alox15在阿霉素诱导心肌病中的作用与潜在机制
-
批准号:JCZRQNB202600846
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: